| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |